RainDance Technologies is a provider of innovative microdroplet-based solutions for human health and disease research, initially in the fields of genomics and molecular epidemiology. The simplicity and speed of our exciting new RainStorm™ microdroplet-based technology enable scientists to achieve breakthroughs in ways that were previously unthinkable or unaffordable.
RainDance was founded by scientists from Harvard University, The Medical Research Centre in Cambridge, England, and the ESPCI in Paris. The company's advisers include three Nobel Prize winners: Jean-Marie Lehn (Chemistry, 1987), Aaron Klug (Chemistry 2002), and Sir Richard Roberts (Physiology or Medicine, 1993), as well as Sir Gregory Winter, joint head of the British Division of Protein and Nucleic Acids Chemistry at the Medical Research Council's Laboratory of Molecular Biology in Cambridge, England.
Based in Lexington, Massachusetts, the company's solutions will be offered to a wide range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the world.
RainDance's initial application will focus on the targeted sequencing of the human genome - one of the fastest-growing segments of the $1 billion DNA sequencing market. This application will enable the high-resolution analysis of genetic variation between individuals and populations at a level unmatched by current methodology. – less–ZoomInfo